invasive bladder cancer Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 2 (2)
Phase 3 (1)

Interventional (3)

Merck Sharp & Dohme Corp. (1)
Rapamycin Holdings, Inc. dba Emtora Biosciences (1)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadbladder cancer

I am/have/hadinvasive bladder cancer

I am/have/hadcarcinoma

I am/have/hadtransurethral resection

I am/have/hadserum pregnancy test

I am/have/hadcarcinoma in situ

I am/have/hadcombination therapy

I am/have/hadbladder tumor

I am/have/hadhysterectomy

I am/have/hadtransitional cell carcinoma of bladder

I am/have/hadbilateral oophorectomy

I am/have/hadbilateral salpingectomy

I am/have/hadoophorectomy

I am/have/hadrecurrent tumor

I am/have/hadintravesical bcg therapy

I am/have/hadmetastatic bladder cancer

I am/have/hadhormone levels

I am/have/hadbladder carcinoma

I am/have/hadhormone level

I am/have/hadtransitional cell carcinoma

added new label for I am/have/had

I am looking for

I am looking forgemcitabine

I am looking forbacillus calmette-guerin

I am looking formitomycin

I am looking forpembrolizumab

I am looking forcisplatin

I am looking forbcg vaccine

I am looking forintravesical bcg

I am looking fordocetaxel

I am looking forfollicle stimulating hormone

I am looking forfluorouracil

I am looking forluteinizing hormone

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

eRapa (encapsulated rapamycin) will be investigated for secondary prevention in patients with diagnosed non-muscle invasive bladder cancer (NMIBC) through a phase II double-blind randomized controlled trial of long-term (one year) prevention with eRapa versus placebo.

2 views
19 Feb, 2024

Multi-country trial
Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with chemoradiotherapy (CRT) versus CRT alone in participants with muscle-invasive bladder cancer (MIBC). The primary hypothesis is that pembrolizumab + chemoradiotherapy is superior to placebo + chemoradiotherapy with respect to bladder intact event-free survival.

cisplatin

invasive bladder cancer

bladder tumor

mitomycin

chemoradiotherapy

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Intravesical Gemcitabine and Docetaxel for BCG na ve Non-muscle Invasive Bladder Cancer

A single-arm, two-stage, open-label, phase 2 study investigating the safety and efficacy of intravesical gemcitabine/docetaxel for bacillus Calmette-Guerin (BCG)-nave patients with non-muscle invasive bladder cancer (NMIBC). All participants will receive an induction course of gemcitabine/docetaxel instillations followed by maintenance instillations if initial efficacy is seen.

carcinoma in situ

bcg vaccine

invasive bladder cancer

bladder carcinoma

hormone level

0 views
19 Feb, 2024